Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].
复制标题
肿瘤学实践中虚拟烟草治疗的杂种1型有效性试验的研究方案[烟雾免费支持研究2.0]。
DOI：
10.1186/s12889-022-13631-w
复制
发表时间：
2022-07-15
影响因子：
4.5
通讯作者：
Park, Elyse R.
中科院分区：
文献类型：
--
作者：
Goshe, Brett M.;Rasmussen, Autumn W.;Wagner, Lynne, I;Sicks, JoRean D.;Gareen, Ilana F.;Carlos, Ruth C.;Herman, Benjamin A.;Walter, Angela Wangari;Regan, Susan;Levy, Douglas E.;Mahon, Irene;Muzikansky, Alona;Neil, Jordan M.;Lui, Michelle;Dilip, Deepika;Malloy, Laura;Gonzalez, Irina;Finkelstein-Fox, Lucy;McCann, Caitlin;Perez, Elissa;Ostroff, Jamie S.;Park, Elyse R.
关键词：
诊断为癌症的患者持续吸烟与不良临床结局相关，但基于证据的烟草使用干预尚未很好地融入社区肿瘤学环境中的癌症护理。本文描述了由ECOG-ACRIN国家癌症研究所（NCI）社区肿瘤学研究计划（NCORP）研究基地进行的一项全国性临床试验的方案，以评估虚拟烟草治疗干预的有效性和在NCORP社区肿瘤学环境中实施烟草治疗的过程。这项双臂、多地点（n：49个NCORP地点）混合1型有效性-实施随机对照试验在最近诊断出患有癌症、报告目前吸烟并在参与的NCORP社区或少数族裔/服务不足地点接受护理的英语和西班牙语患者中比较了虚拟干预治疗（VIT）与增强常规对照（EUC）的有效性。VIT包括多达11次与烟草治疗专家的虚拟咨询会议和长达12周的尼古丁替代疗法（NRT）。EUC组收到转介至NCI戒烟热线。主要研究结果是生化证实的7天点戒烟率。将评估治疗效果的调节因素。该研究通过调查，行政和焦点小组数据，包括范围，可接受性，适当性，保真度，可行性，采用，成本和可持续性结果，从参与NCORP现场工作人员的实施过程进行评估。这项试验将产生关于以证据为基础的虚拟烟草治疗干预措施的有效性的结果，这些干预措施针对被诊断患有癌症的患者，并阐明影响在全国社区肿瘤学环境中实施烟草治疗的障碍和促进因素。在COVID-19时代，虚拟护理解决方案对于最大限度地获得和利用烟草治疗服务至关重要。ClinicalTrials.gov（NCT03808818）on January 18th，2019; Last update posted：May 21st，2020.
Persistent smoking among patients diagnosed with cancer is associated with adverse clinical outcomes, yet an evidence-based tobacco use intervention has not been well-integrated into cancer care in community oncology settings. This paper describes the protocol of a nation-wide clinical trial conducted by the ECOG-ACRIN National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base to assess the effectiveness of a virtual tobacco treatment intervention and the process of implementing tobacco treatment in NCORP community oncology settings. This two-arm, multisite (n: 49 NCORP sites) hybrid type 1 effectiveness-implementation randomized controlled trial compares the effectiveness of a Virtual Intervention Treatment (VIT) versus an Enhanced Usual Control (EUC) among English and Spanish speaking patients recently diagnosed with cancer, reporting current smoking and receiving care at a participating NCORP Community or Minority/Underserved Site. The VIT includes up to 11 virtual counseling sessions with a tobacco treatment specialist and up to 12 weeks of nicotine replacement therapy (NRT). The EUC arm receives a referral to the NCI Quitline. The primary study outcome is biochemically confirmed 7-day point prevalence smoking abstinence. Moderators of treatment effect will be assessed. The study evaluates implementation processes from participating NCORP site staff via survey, administrative, and focus group data, including reach, acceptability, appropriateness, fidelity, feasibility, adoption, cost and sustainability outcomes. This trial will generate findings about the effectiveness of an evidence-based virtual tobacco treatment intervention targeting patients diagnosed with cancer and illuminate barriers and facilitators that influence implementing tobacco treatment into community oncology settings nationally. In the era of COVID-19, virtual care solutions are vital for maximizing access and utilization of tobacco treatment delivery. ClinicalTrials.gov (NCT03808818) on January 18th, 2019; Last update posted: May 21st, 2020.
登录
查看更多内容
DOI：
10.1186/1748-5908-4-50
发表时间：
2009-08-07
期刊：
Implementation science : IS
影响因子：
--
作者：
Damschroder LJ;Aron DC;Keith RE;Kirsh SR;Alexander JA;Lowery JC
通讯作者：
Lowery JC
影响因子：
9.6
作者：
Dresler, CM;Bailey, M;Cooper, JD
通讯作者：
Cooper, JD
DOI：
10.1097/coc.0b013e318059adfc
发表时间：
2007-10-01
影响因子：
2.6
作者：
Garces, Yolanda I.;Schroeder, Darrell R.;Hurt, Richard D.
通讯作者：
Hurt, Richard D.
影响因子：
6.7
作者：
Etter, JF;Perneger, TV
通讯作者：
Perneger, TV
影响因子：
2.3
作者：
Do, KA;Johnson, MM;Spitz, MR
通讯作者：
Spitz, MR